Fusion technology and medical isotope production: Lu-177 for targeted cancer therapy plus neutron testing for defense and aerospace, with long-arc plans for nuclear fuel recycling and fusion energy; cumulative ~$1B+ raised; $150M NantWorks priority access deal for Lu-177; Wisconsin operations
No detailed funding rounds available.
Total known funding: